Noom GLP-1 Review (2026): Med Program Pricing and What You Get

Noom GLP-1 programs sit in an odd spot in 2026. Noom built its name on a psychology-based weight-loss app, then bolted a telehealth prescribing arm — Noom Med — on top of it. The result is one of the cheapest all-in compounded GLP-1 bundles on the market, and one of the few big platforms still selling compounded semaglutide at all after the FDA's 2025-2026 crackdown pushed Hims out of the category entirely.

Direct answer: Noom Med is Noom's telehealth prescribing program. As of June 2026, its cash-pay GLP-1 plans bundle the medication, clinical visits, and the Noom app into one price: Microdose GLP-1Rx at $79 for the first 4 weeks, then $199/month; standard GLP-1Rx at $129 first month, then $249/month (compounded semaglutide); and GLP-1Rx Plus at $149 first month, then $299/month (a compounded GLP-1/GIP option). Ongoing plans are billed quarterly, not monthly. If you want branded Wegovy, Zepbound, or Ozempic, Noom's telehealth-for-branded-med track runs $149 the first month, then $99/month — with the medication billed separately through insurance or cash programs. All plans are FSA/HSA eligible; the compounded plans do not take insurance.

If you are still deciding whether you'd even be approved, start with our GLP-1 qualification guide — Noom's clinicians apply the same BMI math as everyone else.

What Noom Med Actually Is

Noom Med is a telehealth layer: you complete an intake survey covering health history and weight-loss goals, a licensed clinician reviews it, and — if you meet criteria — prescribes a GLP-1. The medication ships from a partner pharmacy, and the subscription includes unlimited clinician access, refills where clinically appropriate, dose-optimization guidance, and Noom's behavior-change program with 1:1 coaching.

The pitch is that medication plus behavior change beats medication alone. That part is fair — the appetite window a GLP-1 opens is easier to use with structured food and habit tracking. The catch is that you are paying for the bundle whether or not you use the app side.

Noom GLP-1 Plans and Pricing (June 2026)

Three pricing details matter more than the headline numbers:

1. Quarterly billing. After the intro period, Noom charges roughly three months at once ($597 for microdose, ~$747 for GLP-1Rx). There is no mid-cycle refund lever, so the real commitment per decision is quarterly.
2. The advertised entry prices are intro prices. "$79" is your first four weeks of microdosing, not your run rate. Budget against $199-$299/month.
3. On the branded track, the $99/month is just the program. Wegovy or Zepbound costs land on top — your copay if insured, or cash-program pricing (roughly $349/month for Wegovy via NovoCare, $299-$449/month for Zepbound vials via LillyDirect) if not. We walk through that whole path in how to get Zepbound.

Which GLP-1s Noom Prescribes Now

As of June 2026, Noom Med's menu spans compounded semaglutide (microdose and full dose), a compounded GLP-1/GIP "Plus" option, branded Wegovy, Zepbound, and Ozempic (Ozempic for type 2 diabetes — see how to get Ozempic for why weight-loss patients get routed to Wegovy instead), the new oral Wegovy pill, generic liraglutide, and metformin as a budget pill. That is the widest menu of any major platform.

The Compounded Semaglutide Question

This is the part of any honest Noom GLP-1 review that needs dates. The FDA declared the semaglutide shortage resolved in early 2025, which formally ended mass compounding of "essentially a copy" versions. Most large players retreated; Hims discontinued compounded GLP-1s for new patients after settling with Novo Nordisk in March 2026. Noom kept going through the patient-specific 503A prescription route — and in April 2026 the FDA proposed removing semaglutide and tirzepatide from the 503B bulk compounding list and issued roughly 30 warning letters, with a comment period running through June 29, 2026.

Noom's own pages now carry the disclaimer twice: "The FDA does not review any compounded medication for safety or efficacy." Practically, that means two things. First, the $199-$299 plans buy a non-FDA-approved formulation. Second, the regulatory floor under those plans could shift again within months. If you start a compounded plan, have a branded exit plan — insurance, NovoCare, or LillyDirect pricing.

Noom vs Hims vs Ro

The pattern: Hims and Ro are now branded-medication storefronts with a membership fee. Noom is the only one of the three where a sub-$200/month all-in compounded option still exists — and the only one where the coaching layer is genuinely the main product.

Pros and Cons

Pros: cheapest all-in compounded pricing among major platforms; medication, clinician, and app in one bill; widest medication menu including oral options; FSA/HSA eligible; real behavior-change content rather than a token app.

Cons: quarterly billing with no monthly off-ramp; intro prices mask the run rate; compounded plans are not FDA-approved products and sit on shifting regulatory ground; branded-track medication costs are extra; results claims ("up to 17 lbs in 60 days") describe the top quartile, with the average closer to 13 lbs.

Who Noom Med Fits

Noom fits a cash-pay patient who wants the lowest bundled monthly number and actually wants coaching; an insured patient can use the $99/month branded track as a prescription-plus-paperwork service. It is a poor fit if you want brand-name medication at the lowest possible markup (go direct via LillyDirect or NovoCare routes) or if quarterly prepayment is a dealbreaker. Other platforms are compared in our GLP-1 online guide.

Don't qualify, or can't get it covered? Yücca telehealth — online evaluation, doctor-prescribed compounded Semaglutide+ or Tirzepatide+ filled by a licensed US pharmacy, from $146/month. (Partner link: we may earn a commission, at no extra cost to you.)

Frequently Asked Questions

How much does Noom GLP-1 cost per month? Compounded plans: $199/month (microdose), $249/month (standard), or $299/month (GLP-1/GIP Plus) after intro pricing of $79-$149, billed quarterly. The branded-medication track is $99/month after a $149 first month, plus the medication itself.

Does Noom prescribe real Wegovy or Zepbound? Yes. Noom Med can prescribe branded Wegovy, Zepbound, and Ozempic (and oral Wegovy) on its telehealth track, with insurance support or cash-pay programs covering the medication separately.

Is Noom's compounded semaglutide still legal in 2026? It remains available via patient-specific 503A prescriptions, but the FDA's April 2026 proposal and warning letters have tightened the category, and Noom discloses that compounded medications are not FDA-reviewed for safety or efficacy.

Does Noom GLP-1 take insurance? Not for the compounded plans — those are cash-pay (FSA/HSA eligible). Insurance can cover branded medication on the telehealth-for-branded-med track, where Noom's fee is $99/month after the first month.

Do you have to use the Noom app to get the medication? The app and coaching come bundled with every plan and are part of the price. You are not forced to log meals, but you cannot unbundle them for a discount.

Last reviewed: June 13, 2026

Sources

• Noom Med Plans & Pricing — Noom
• Noom Med — GLP-1 Medications for Weight Loss — Noom
• Microdosing GLP-1 — Noom Microdose GLP-1Rx Program — Noom
• Noom GLP-1 Weight Loss Review — U.S. News
• Noom Med Review 2026: GLP-1 Program Pricing and Results — Telehealth Ally
• Compounded Semaglutide & Tirzepatide Legal Status 2026: FDA 503B Ban — Loti Labs
• Is Compounded Semaglutide Still Legal? (2026 Update) — GLP-1 After Denial
• Weight Loss Program Pricing — Ro
• Ro introduces one-month $199 Wegovy new patient offer — Ro Press